1-3 of 3
Ruixin Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Yifan Kong, Yanquan Zhang, Fengyi Mao, Zhuangzhuang Zhang, Zhiguo Li, Ruixin Wang, Jinghui Liu, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (12): 2490–2501.
https://doi.org/10.1158/1535-7163.MCT-19-0874
Published: 02 December 2020
View article titled, Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer
Open the PDF for Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer

Fengyi Mao, Jie Li, Qian Luo, Ruixin Wang, Yifan Kong, Colin Carlock, Zian Liu, Bennet D. Elzey, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1554–1565.
https://doi.org/10.1158/1535-7163.MCT-17-0945
Published: 01 July 2018
View article titled, Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
Open the PDF for Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer

Jie Li, Ruixin Wang, Yifan Kong, Meaghan M. Broman, Colin Carlock, Long Chen, Zhiguo Li, Elia Farah, Timothy L. Ratliff, Xiaoqi Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (3): 469–479.
https://doi.org/10.1158/1535-7163.MCT-16-0361
Published: 02 March 2017
View article titled, Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
Open the PDF for Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data